Lori Marshall, MD
Interventional Pain Medicine · Jackson, MSNPI 1144428749
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $472 and has fallen 85.2% since, to $70 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MS, where the typical reported total is $2,720.
Across 57 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$173
- Pfizer$115
- Takeda Pharmaceuticals U.S.A., Inc.$101
- Medtronic$65
- Hikma Pharmaceuticals USA$59
- Collegium Pharmaceutical, Inc.$57
- plus $367 from 15 others
What the payments were for
- Food & beverage$937100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 7 | $173 |
| Pfizer | 9 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $101 |
| Medtronic(2 entities) | 4 | $65 |
| Hikma Pharmaceuticals USA | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 4 | $57 |
| Astellas Pharma US Inc | 2 | $46 |
| MDD US Operations, LLC | 3 | $43 |
| AstraZeneca | 3 | $37 |
| Forte Bio-pharma LLC | 2 | $35 |
| Biotronik NRO, Inc. | 1 | $31 |
| Abbott | 2 | $31 |
| Scilex Pharmaceuticals Inc. | 2 | $28 |
| Nalu Medical, Inc. | 1 | $20 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Boston Scientific | 1 | $15 |
| Si-bone, Inc. | 1 | $15 |
| AbbVie | 1 | $13 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Indivior Inc. | 1 | $11 |
| Daiichi Sankyo Inc. | 1 | $11 |
How this compares
$937 in reported general payments places this provider in the 20th percentile of 24 interventional pain medicine providers in Mississippi.
See all interventional pain medicine providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 33 | $6,651 |
| OxycontinOxycodone Hcl | 11 | $5,806 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 108 | $2,732 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 108 | $2,279 |
| Gabapentin | 82 | $1,654 |
| Diclofenac Sodium | 32 | $1,468 |
| Pregabalin | 55 | $1,223 |
| Naloxone Hcl | 17 | $1,002 |
| Oxycodone Hcl | 68 | $942 |
| Methadone Hcl | 53 | $916 |
| Tizanidine Hcl | 39 | $733 |
| Morphine Sulfate ErMorphine Sulfate | 30 | $690 |
| Cyclobenzaprine Hcl | 29 | $400 |
| Methocarbamol | 18 | $230 |
| Amitriptyline Hcl | 12 | $151 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Jackson
- John LutzJackson$5K
- Alfred LyonsJackson$722
- Leonel VanceMadison$21K
- Eric PearsonMeridian$19K
- Charles MartinMeridian$18K
- Matthew BlanchardGulfport$10K
- Kenneth StaggsMeridian$5K
- Madelyn CraigMadison$5K
- Michael SteuerSouthaven$4K
- Kelly ColemanVancleave$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.